BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 8621615)

  • 1. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice.
    Zhang B; Graziano MP; Doebber TW; Leibowitz MD; White-Carrington S; Szalkowski DM; Hey PJ; Wu M; Cullinan CA; Bailey P; Lollmann B; Frederich R; Flier JS; Strader CD; Smith RG
    J Biol Chem; 1996 Apr; 271(16):9455-9. PubMed ID: 8621615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
    Cai XJ; Lister CA; Buckingham RE; Pickavance L; Wilding J; Arch JR; Wilson S; Williams G
    Brain Res Mol Brain Res; 2000 Apr; 77(1):131-7. PubMed ID: 10814839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese (db/db mice, fa/fa rats) rodents.
    Igel M; Kainulainen H; Brauers A; Becker W; Herberg L; Joost HG
    Diabetologia; 1996 Jul; 39(7):758-65. PubMed ID: 8817099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats.
    Ogawa Y; Masuzaki H; Isse N; Okazaki T; Mori K; Shigemoto M; Satoh N; Tamura N; Hosoda K; Yoshimasa Y
    J Clin Invest; 1995 Sep; 96(3):1647-52. PubMed ID: 7657834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
    Furuta M; Yano Y; Gabazza EC; Araki-Sasaki R; Tanaka T; Katsuki A; Hori Y; Nakatani K; Sumida Y; Adachi Y
    Diabetes Res Clin Pract; 2002 Jun; 56(3):159-71. PubMed ID: 11947963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent antidiabetic effects of rivoglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, in obese diabetic rodent models.
    Kanda S; Nakashima R; Takahashi K; Tanaka J; Ogawa J; Ogata T; Yachi M; Araki K; Ohsumi J
    J Pharmacol Sci; 2009 Oct; 111(2):155-66. PubMed ID: 19809220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
    Alemzadeh R; Tushaus KM
    Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes.
    MacDougald OA; Hwang CS; Fan H; Lane MD
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9034-7. PubMed ID: 7568067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).
    Young AA; Gedulin BR; Bhavsar S; Bodkin N; Jodka C; Hansen B; Denaro M
    Diabetes; 1999 May; 48(5):1026-34. PubMed ID: 10331407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
    Young PW; Cawthorne MA; Coyle PJ; Holder JC; Holman GD; Kozka IJ; Kirkham DM; Lister CA; Smith SA
    Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
    J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of obese (ob) mRNA and plasma leptin levels in rhesus monkeys. Effects of insulin, body weight, and non-insulin-dependent diabetes mellitus.
    Hotta K; Gustafson TA; Ortmeyer HK; Bodkin NL; Nicolson MA; Hansen BC
    J Biol Chem; 1996 Oct; 271(41):25327-31. PubMed ID: 8810296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes.
    Chakrabarti R; Vikramadithyan RK; Kumar MP; Kumar SK; Mamidi NV; Misra P; Suresh J; Hiriyan J; Rao CS; Rajagopalan R
    Diabetes Obes Metab; 2002 Sep; 4(5):319-28. PubMed ID: 12190995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats.
    Ide T; Nakazawa T; Mochizuki T; Murakami K
    Metabolism; 2000 Apr; 49(4):521-5. PubMed ID: 10778879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.
    Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P
    Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.